Astellas Pharma US Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Astellas Pharma US's estimated annual revenue is currently $46.6M per year.(i)
  • Astellas Pharma US's estimated revenue per employee is $261,978

Employee Data

  • Astellas Pharma US has 178 Employees.(i)
  • Astellas Pharma US grew their employee count by -4% last year.

Astellas Pharma US's People

NameTitleEmail/Phone
1
Chief Medical Officer, Head Medical and DevelopmentReveal Email/Phone
2
Chief Technology Architect/ Programme Delivery Lead- Global Commercial Data and AnalyticsReveal Email/Phone
3
National VP SalesReveal Email/Phone
4
Head Global Commercial Strategy, Planning and TransformationReveal Email/Phone
5
SVP, Head Medical & Development Strategy & Operations, Astellas PharmaReveal Email/Phone
6
SVP Commercial StrategyReveal Email/Phone
7
VP Global Brand Lead - XTANDIReveal Email/Phone
8
Head Commercial AlliancesReveal Email/Phone
9
Head Global Market Access Excellence and CapabilitiesReveal Email/Phone
10
Head Market Access and Government AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is Astellas Pharma US?

Astellas Pharma US, Inc., a US subsidiary of Tokyo-based Astellas Pharma Inc., is a research-based pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Established on April 1, 2005, Astellas Pharma Inc. was formed through a merger that combined the outstanding research, development and marketing capabilities of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. Astellas ranks among the top 20 pharmaceutical companies in the world and will continue to grow as a competitive company in the world pharmaceutical market. For more information on Astellas Pharma US, Inc.,

keywords:N/A

N/A

Total Funding

178

Number of Employees

$46.6M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Astellas Pharma US News

2022-04-20 - Chronic Idiopathic Constipation Market Size, Scope And ...

GlaxoSmithKline Plc., Astellas Pharma Synergy Pharmaceuticals Bayer AG, Allergan Plc., Ironwood Pharmaceuticals Sanofi S.A., Pfizer, Inc.

2022-04-20 - Overactive Bladder Drug Market Size 2022-2029| Key Players ...

Astellas Pharma; Inc. (japan); Pfizer; Inc. (us); Teva Pharmaceutical Industries Limited (israel); Allergan; Plc (ireland)...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.7M18033%N/A
#2
N/A18258%N/A
#3
$47.2M1899%N/A
#4
$48.2M193-15%N/A
#5
$60M20216%N/A